Page last updated: 2024-08-21

18-hydroxycorticosterone and Pituitary Neoplasms

18-hydroxycorticosterone has been researched along with Pituitary Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biglieri, EG; Brust, N; Chang, BC; Hirai, J; Kater, CE; Rost, CR; Schambelan, M1

Other Studies

1 other study(ies) available for 18-hydroxycorticosterone and Pituitary Neoplasms

ArticleYear
The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production.
    The Journal of clinical endocrinology and metabolism, 1985, Volume: 60, Issue:2

    Topics: 18-Hydroxycorticosterone; Adenoma; Adolescent; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Child; Child, Preschool; Corticosterone; Cushing Syndrome; Cytochrome P-450 CYP11B2; Female; Humans; Hydrocortisone; Infant; Kidney Diseases; Male; Middle Aged; Mixed Function Oxygenases; Pituitary Diseases; Pituitary Neoplasms; Potassium; Renin; Renin-Angiotensin System

1985